Covered, compounding — small income, buyback-led returns. A 0.67% yield on a 10.44% trailing payout is covered and growing: $0.78 a quarter, raised from $0.72 at the start of 2026, with five years of increases counted on a trailing basis. But the dividend is a side channel — the company returns far more through buybacks (about 9% buyback yield) than through the payout, so income holders get growth without much cash.
Key risk: Reimbursement and labor costs — hospital margins ride payer rates and nurse staffing costs, and buyback-funded returns depend on leverage staying cheap.
Changes if: The payout is raised materially toward the cash now spent on buybacks, or the buyback pace slows and the dividend takes its place. Until then the income stays small.
- ✓Payout-coverage check: 10.44% trailing payout — the $3.12 indicated dividend is covered many times over by trailing earnings.
- !Yield check: 0.67% indicated — $0.78/qtr × 4 at the $469.03 close on Oct. 23, 2026. Real cash, but small as income for a single stock.
- ✓Dividend growth check: Raised at the start of 2026, from $0.72 to $0.78 a quarter, about 8.5% growth, with five years of increases counted on a trailing basis.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.